How important are ALT and AST abnormalities when prescribing psychotropics? Should you adjust dosing in patients with elevated ALT and AST? Does inflammation alter drug kinetics?

Faculty: Jonathan Meyer, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.

• Learn more about our memberships here
• Earn 1 CME: Use of Psychotropics in Patients With Hepatic Issues
• Diagnosis and Impact on Drug Metabolism of Nonalcoholic Fatty Liver Disease: Steatosis and Nonalcoholic Steatohepatitis